Alzheimer’s disease (AD) is a vital medical/social problem in EU, but currently, there is not an effective method for the early diagnosis of AD.

Integrated by neuroscientists, nanotechnologists, molecular imaging experts, clinicians and Small/Medium/Large Enterprises in an exclusive consortium, PANA project seeks the goal to develop new effective early diagnostic and therapeutic strategies to help in delaying the appearance of the most adverse symptoms of this disease, using nanotechnology.

News & events


This project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 686009


Clinical Neuroscience Research Laboratory
University Clinical Hospital Santiago
A Building, -4 Floor
E15706 A Coruña, Spain
View map

At we use own and third party cookies to offer you a better service and obtain anonymous statistical data. If you continue browsing we consider that you accept its use. You can get more information, or how to change your settings in our cookies policy.